We are tackling the biggest medical challenges of our generation.

The breadth and depth of our pipeline demonstrates the power of the CONVERGE^® platform. All pipeline programs have been discovered and developed on our proprietary platform.

Good treatments have long been developed for diseases with well-understood biology and predictive disease models. All that remains are diseases with complex biology, where animal and cell models do not predict whether drugs work. Accelerating the pace of bringing effective, new medicines to these patients is one of the greatest opportunities for humanity.

The CONVERGE^® platform addresses diseases where biology is the bottleneck. Our programs target therapeutic areas where:

• Multi-factorial components (genetics, environment, and time) intersect in complex ways to culminate in overt disease
• Animal or cell models do not predict human efficacy
• There is high unmet need, no disease-modifying therapies, or significant shortcomings with existing treatment paradigms